p120 catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia

Journal of Neuroscience Research

Volumn 88, Issue 16, 2010, Pages 3621-3634

  Céspedes Rubio, Angel ^a,b   Jurado, Francisco Wandosell ^c   Cardona Gómez, Gloria Patricia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD DEL TOLIMA   (Colombia)

^c CSIC   (Spain)

Author keywords

Adhesion proteins; Atorvastatin; Cerebral ischemia; Neuronal plasticity; Neuroprotection

Indexed keywords

ALPHA N CATENIN; ATORVASTATIN; CARBOXYMETHYLCELLULOSE; CATENIN; FOCAL ADHESION KINASE; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 42; MITOGEN ACTIVATED PROTEIN KINASE 44; PLACEBO; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN KINASE B; PROTEIN P120; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE; SYNAPTIC ADHESION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DRUG EFFICACY; GLIA CELL; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MEDIATOR; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; RECEPTOR UPREGULATION; REPERFUSION INJURY; TEMPORAL CORTEX;

ALPHA CATENIN; ANALYSIS OF VARIANCE; ANIMALS; BRAIN ISCHEMIA; CATENINS; CELL ADHESION MOLECULES; CELL DEATH; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; HIPPOCAMPUS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFARCTION, MIDDLE CEREBRAL ARTERY; LONGITUDINAL STUDIES; MALE; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; PROTEIN ISOFORMS; PYRROLES; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; SYNAPSES;

EID: 78049425264     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22511     Document Type: Article

References (59)

1. Anastasiadis PZ. 2007. p120-ctn: A nexus for contextual signaling via Rho GTPases. Biochim Biophys Acta Mol Cell Res 1773: 34-46.
2. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. 1986. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476.
3. Belayev L, Busto R, Zhao W, Fernandez G, Ginsberg MD. 1999. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res 833: 181-190.
4. Berger C, Xia F, Maurer MH, Schwab S. 2008. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev 58: 48-56.
5. Bindokas PV, Miller RJ. 1995. Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons. J Neurosci 15: 6999-7011.
6. Bustelo XR, Sauzeau V, Berenjeno IM. 2007 GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29: 356-370.
7. Buttmann M, Lorenz A, Weishaupt A, Rieckmann P. 2007. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. J Neurochem 102: 1001-1008.
8. Carmichael ST. 2005. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2: 396-409.
9. Costain WJ, Rasquinha I, Sandhu JK, Rippstein P, Zurakowski B, Slinn J, MacManus JP, Stanimirovic DB. 2008. Cerebral ischemia causes dysregulation of synaptic adhesion in mouse synaptosomes. J Cereb Blood Flow Metab 28: 99-110.
10. Dalva MB, McClelland AC, Kayser MS. 2007. Cell adhesion molecules: signalling functions at the synapse. Nat Rev Neurosci 8: 206-220.
11. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Panda S, Ewing JR, Chopp M. 2006. MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin. J Neurol Sci 246: 39-147.
12. Durukan A, Tatlisumak T. 2007. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87: 179-197.
13. Elia LP, Yamamoto M, Zang K, Reichardt LF. 2006. p120 Catenin regulates dendritic spine and synapse development through Rho-family GTPases and cadherins. Neuron 51: 43-56.
14. Endo H, Nito C, Kamada H, Nishi T, Chan PH. 2006. Activation of the Akt/GSK3 signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 26: 1479-1489.
15. Fukata M, Kaibuchi K. 2001. Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat Rev Mol Cell Biol 2: 887-897.
16. Gao X, Zhang H, Takahashi T, Hsieh J, Liao J, Steinberg GK, Zhao H. 2008a. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 105: 943-955.
17. Gao X, Ren C, Zhao H. 2008b. Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res 86: 2505-2511.
18. Gelosa P, Cimino M, Pignieri A, Tremoli E, Guerrini U, Sironi L. 2007. The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manage 3: 567-577.
19. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, Li H-C, Schutte M, Gordon R, Holstein GR, Martinelli G, Mehta P, Friedrich VL, Robakis NK. 1999. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell 4: 893-902.
20. Greenwood SM, Connolly CN. 2007. Dendritic and mitochondrial changes during glutamate excitotoxicity. Neuropharmacology 53: 891-898.
21. Hoskison MM, Shuttleworth CW. 2006. Microtubule disruption, not calpain-dependent loss of MAP2, contributes to enduring NMDA-induced dendritic dysfunction in acute hippocampal slices. Exp Neurol 202: 302-312.
22. Hoskison MM, Yanagawa Y, Obata K, Shuttleworth CW. 2007. Calcium-dependent NMDA-induced dendritic injury and MAP2 loss in acute hippocampal slices. Neuroscience 145: 66-79.
23. Ifergan I, Wosik K, Cayrol R, Kébir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Alexandre Prat A. 2006. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ann Neurol 60: 45-55.
24. Ii M, Losordo DW. 2007. Statins and the endothelium. Vasc Pharmacol 46: 1-9.
25. Jang YN, Jung YS, Lee SH, Moon CH, Kim CH, Baik EJ. 2009. Calpain-mediated N-cadherin proteolytic processing in brain injury. J Neurosci 29: 5974-5984.
26. Joshi CN, Jain SK, Murthy PSR. 2004. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Protoc 13: 11-17.
27. Kalayci R, Kaya M, Elmas I, Arican N, Ahishali B, Uzun H, Bilgic B, Kucuk M, Kudat H. 2005. Effects of atorvastatin on blood-brain barrier permeability during l-NAME hypertension followed by angiotensin-II in rats. Brain Res 1042: 184-193.
28. Kranenburg O, Poland M, van Horck FPG, Drechsel D, Hall A, Moolenaar WH. 1999. Activation of RhoA by lysophosphatidic acid and G12/13 subunits in neuronal cells: induction of neurite retraction. Mol Biol Cell 10: 1851-1857.
29. Kwiatkowsk AV, Weis WI, Nelson WJ. 2007. Catenins: playing both sides of the synapse. Curr Opin Cell Biol 19: 551-556.
30. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui D-S, Yang S-X, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Böhm M, Schoen FJ, Moskowitz MA, Liao JK. 2000. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 106: 15-24.
31. Liao JK. 2005. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96: 24-33.
32. Liao JK, Laufs U. 2005. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118.
33. Matter C, Pribadi M, Liu X, Trachtenberg JT. 2009. Delta-catenin is required for the maintenance of neural structure and function in mature cortex in vivo. Neuron 64: 320-327.
34. Matucz É, Móricz K, Gigler G, Benedek A, Barkóczy J, Lévay G, Hársing LG Jr, Szénási G. 2006. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats. Brain Res 1123: 60-67.
35. Mège R-M, Gavard J, Lambert M. 2006. Regulation of cell-cell junctions by the cytoskeleton. Curr Opin Cell Biol 18: 541-548.
36. O'Kane EM, Stone TW, Morris BJ. 2003. Activation of Rho GTPases by synaptic transmission in the hippocampus. J Neurochem 87: 1309-1312.
37. Peña-Tapia PG, Díaz AH, Torres JL. 2004. Oclusión endovascular permanente de la arteria cerebral media en ratas Wistar: descripción del abordaje a través de la arteria carótida interna. Rev Neurol 39: 1011-1016.
38. Poli A. 2001. Atorvastatin: pharmacological characteristics and lipid-lowering effects. Drugs 67(Suppl 1): 3-15.
39. Rosenkranz JA, Frick A, Johnston D. 2009. Kinase-dependent modification of dendritic excitability after long-term potentiation. J Physiol 587: 115-125.
40. Roulston CL, Callaway JK, Jarrott B, Woodman OL, Dusting GJ. 2008. Using behaviour to predict stroke severity in conscious rats: post-stroke treatment with 3', 4'-dihydroxyflavonol improves recovery. Eur J Pharmacol 584: 100-110.
41. Salinas PC, Price SR. 2005. Cadherins and catenins in synapse development. Curr Opin Neurobiol 15: 73-80.
42. Saposnik G, Del Brutto OH. 2003. Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke 34: 2103-2107.
43. Sayas CL, Moreno-Flores MT, Avila J, Wandosell F. 1999. The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like tau phosphorylation. J Biol Chem 274: 37046-37052.
44. Semenova MM, Mäki-Hokkonen AM, Cao J, Komarovski V, Forsberg KM, Koistinaho M, Coffey ET, Courtney MJ. 2007. Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death. Nat Neurosci 10: 436-443.
45. Shamloo M, Rytter A, Wieloch T. 1999. Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 93: 81-88.
46. Shuaib A, Wang CX, Yang T, Noor R. 2002. Effects of nonpeptideV1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 33: 3033-3037.
47. Tanaka H, Shan W, Phillips GR, Arndt K, Bozdagi O, Shapiro L, Huntley GW, Benson DL, Colman DR. 2000. Molecular modification of N-cadherin in response to synaptic activity. Neuron 25: 93-107.
48. Togashi H, Abe K, Mizoguchi A, Takaoka K, Chisaka O. 2002. Cadherin regulates dendritic spine morphogenesis. Neuron 35: 77-89.
49. Trapp T, Oláh L, Hölker I, Besselmann M, Tiesler C, Maeda K, Hossmann KA. 2001 GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice. Mol Cell Neurosci 17: 883-894.
50. Vorbrodt AW, Dobrogowska DH. 2004. Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Fol Histochem Cytobiol 42: 67-75.
51. Wang H, Lynch JR, Song P, Yang H-J, Yates RB, Mace B, Warner DS, Guyton JR, Laskowitz DT. 2007. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 206: 59-69.
52. Xiao K, Oasa RG, Chiassona CM, Kowalczyka AP. 2007. Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta Mol Cell Res 1773: 8-16.
53. Yamagata M, Sanes JR, Weiner JA. 2003. Synaptic adhesion molecules. Curr Opin Cell Biol 15: 621-632.
54. Yang Y, Shuaib A, Li Q. 1998. Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method. J Neurosci Methods 84: 9-16.
55. Yrjänheikki J, Koistinaho J, Kettunen M, Kauppinen RA, Appel K, Fiebich BL. 2005. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 1052: 174-179.
56. Zadran S, Qin Q, Bi X, Zadran H, Kim Y, Foy MR, Thompson R, Baudry M. 2009. 17-b-Estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proc Natl Acad Sci U S A 106: 21936-21941.
57. Zhang H-L, Huang ZH, Zhu Y, Liang Z-Q, Han R, Wang X-X, Chase TN, Qin Z-H. 2005. Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia. Brain Res 1039: 203-206.
58. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM, Steinberg GK. 2005. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25: 9794-9806.
59. Zuo Y, Lin A, Chang P, Gan WB. 2005. Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron 46: 181-189.